This research aimed to analyze the effect of IFITM1 on the radioresistance of oral neoplasm. Using a multi-group heat map from GSE9716 analysis of the GEO database, IFITM1 was determined to be a relevant radioresistance gene. The TCGA database was analyzed before the expression of IFITM1 was analyzed. IFITM1 expression was quantified by quantitative RT-PCR and immunohistochemistry in 19 paired oral neoplasm cases. The effects of time and dose of radiation on IFITM1 expression level in CAL27
amounts to more than one fatality every hour due to oral cancer.
Worldwide, approximately 300 000 cases and 145 000 deaths are reported annually. 2 Research dedicated to radiotherapy tolerance is on the rise, and the present research seeks to contribute to the treatment strategies of oral neoplasm using radiotherapy in combination with the inhibition of IFITM1.
Radiotherapy is regularly used in cancer treatment, with 40% to 60% of all cancer patients accepting the treatment. 3 As an example, stereotactic ablative radiation therapy is one application of radiotherapy gaining popularity in the management of many disease types, including prostate cancer. 4 Stereotactic radiosurgery involves delivering a single high dose over a small area while sparing the surrounding healthy tissue. Consequently, this treatment requires rigorous precision in immobilization and patient positioning. 5 Resistance to chemotherapy remains problematic. Up to one-third of LABC are resistant to chemotherapy and/or hormone therapy and remain inoperable.
It is possible to treat such patients with radiotherapy to reduce tumor burden and allow resection. At the Brazilian National Cancer Institute many patients are diagnosed when the disease is locally advanced, and a significant proportion thus have a poor response to neoadjuvant chemotherapy regimens involving anthracyclines ± taxanes ± trastuzumab. Therefore, other therapies are required, such as radiotherapy, to reduce the tumor burden with the goal of surgical resection. 6 Radiotherapy is a crucial method commonly used in cancer management. Hence, this study was designed to apply radiotherapy in oral neoplasm.
Interferon-induced transmembrane protein 1 (IFITM1) is a member of the IFN-inducible transmembrane protein family and of the multimeric complex involved in cell adhesion signals and transduction of anti-proliferation. 7 Following its recognition in hologenome expression analysis of tumor cells, the effects of IFITM1 began to be widely studied, which accordingly led to the recognition of its role in drug response and cell invasion. More recently, a set of studies have illustrated correlations between overexpression of IFITM1 and the progression of cancers in diverse tissues, including ovarian cancer, head and neck cancer, colorectal cancer, gastric cancer, lymphoma, leukemia and cervical squamous cell carcinoma. 8 Hence, it is very likely that IFITM1 may also hold hitherto undiscovered value elsewhere. Thus, the present study combines IFITM1 and radiotherapy to make new headway in the treatment of oral neoplasm.
This research contains extensive experiments, including quantitative RT-PCR (qRT-PCR), immunohistochemistry, colony formation, flow cytometry, western blot, immunofluorescence and a nude mice tumor model, to verify the effects of radiotherapy and the expression of IFITM1 with change of time and dose in oral neoplasm, to observe cell proliferation and cell apoptosis rates, to detect caspase-3 viability, expression and γ-H2AX, to measure the STAT1/2/3/ p21-related protein and phosphorylation changes and to demonstrate the effect of IFITM1 on oral neoplasm cells radioresistance.
The results indicate that inhibition of IFITM1 in combination with radiotherapy could, indeed, inhibit oral neoplasm cells; therefore, this research may lead to some improvements in the treatment of oral neoplasm.
| MATERIALS AND METHODS

| Patients and samples
The study included 19 cancer tissues and adjacent tissues before radio- 
| Cell transfection
BLOCK-iTTM RNAi Designer (Invitrogen, Carlsbad, CA, USA) was used to design the interfering nucleotide sequence. Meanwhile, the unrelated nucleic acid sequences of the same base number, designed and synthesized in the same way, served as a negative control (related sequences are listed in Table 1 ). They were then transformed to competent cells for expansion. Positive clones were picked and the recom- 
| Immunohistochemistry
Paraffin-embedded pathological sections were deparaffinized and rehydrated. Antigens were then retrieved using PBS containing 0.1% trypsin at 37°C for 30 minutes. Before antibody reactions, endogenous peroxidase was inactivated with 5 minutes 3% hydrogen peroxide incubation at room temperature followed by rinsing with PBS.
Samples were incubated with 5% BSA for 10 minutes and primary antibodies IFITM1 (ab224063, 1:200, Abcam, Cambridge, MA, USA)
were diluted and added to slides. Secondary antibody horseradish enzyme-labeled goat anti-rabbit IgG was applied to each slide, which were then incubated for 30 minutes and washed three times with PBS. Finally, each specimen-containing slide was developed using chromogen DAB for 20 seconds, and counterstained with hematoxylin for 1 minute. After staining was completed, slides were sealed and observed by two independent reviewers under a microscope. The expression level of IFITM1 was evaluated by total score, which was taken as dyeing intensity score plus dyeing range score (the ratio of positive stained cells in the cell membrane and cytoplasm).
| Extraction of RNA and quantitative RT-PCR
RNA primers (primers used are exhibited in Table 2 ) were designed and colligated by Sangon Biotech (Shanghai, China). The total RNA of cells was extracted using Trizol. Next, the concentration and purity of the total RNA were measured in the same way. Total RNA were reverse-transcribed into cRNA using a First Strand Synthesis Kit (Thermo Fisher Scientific, Waltham, MA, USA) according to manufacturer guidelines. First strand cDNA was stored at −20°C before real-time PCR, which subjected cDNA to the ABI PRISM 7000
Sequence Detection System using Maxima SYBR Green qPCR Master Mix (2×) (Thermo Fisher Scientific). The samples were amplified using β-actin as internal control and reaction conditions were as follows: original denaturation at 95°C for 5 minutes with another extension at 72°C for 5 minutes, followed by 40 cycles of 95°C for 15 seconds and 60°C for 30 seconds. After all of this was completed, results were analyzed using Step One Software v2.1 in
, which analyzed the gene relative expression level.
| Radiotherapy
Cells and mice were irradiated at doses 2, 4, 6 and 8 Gy/min with 250 kV X-rays (Philips RT250, Kimtron Medical) at a distance of approximately 50 cm from the radiation source.
| Colony formation and survival analysis
Adherent cells were digested with trypsin and released into 96-well plates, at 500 cells per well. Single cell suspension was transferred to 10-mL tubes. Into these tubes, 3 mL 2 × RPMI + 10% FCS and 3 mL 0.7% agarose were added and mixed by gentle swirling. Finally, MAP3K9  NUDT3  EPS8L1  SH3YL1  MAPK13  CEACAM6  CD59  MAL  NDRG2  CYB5A  FA2H  NAGK  CTNND1 /// TMX2−CTNND1  CST6  TECR  GPX4  ANXA9  SCNN1A  PPL  LYPD3  GAB2  SERPINB13  MYCL  CLIC3  EVPL  EPS8L2  RIOK3  CYB5R1  CDKN1A  DSG1  DSC1  PROS1  CYP2C18  KLK11  SCEL  ALOX12B  ELF5  SCD  RAP2C  CUTA  EIF3F  PKP3  RPL10A  FTL  NOL3  CRABP2  PKP1  HDAC5  EEF1G /// MIR3654  ANK3  KRT76  DBI  SIDT2  KRT15  KRT13  GM2A  KRT4  CTSD  GPR56  AHNAK2  PPP1R3C  EIF3L  UBE2G1  GID8  DUSP22  SUSD4  SSR1  ATXN1  PUM1  CAMK2N1  TRIM29  NFKBIA  PDLIM4  BPTF  EXPH5  TRIM62  TPCN1  FXYD3  PLD1  CLCA4 MIA Optical density was detected using a microplate reader at 490 nm.
Finally, the expression of caspase-3 protein was verified by western blot.
| γH2AX detected by immunofluorescence assay
Next, 1 × 10 4 cells were seeded in a 24-well plate containing slides.
After different transfection treatments, medium was placed into a constant temperature oven at 37°C with 5% CO 2 . Cells were exposed to 8-Gy radiation. After 24 hours, medium was washed three times with pre-warmed 1× PBS for 10 minutes each. Air-dried slides were fixed with 4% formaldehyde in TBS for 15-20 minutes at room temperature and washed three times with 1× PBS for 10 minutes each. Cells were then permeabilized with 0.2% Triton X-100 for 4 minutes and washed three times with 1× PBS for 10 minutes each. These cells were then blocked in 5% BSA at room temperature for 30 minutes. γ-H2AX primary antibody (Abcam) was added at 4°C
overnight. Cells were washed three times with 1× PBS for 10 minutes each. Next, Cy3 fluorescently labeled secondary antibody (Abcam) was added for 1 hour at room temperature in darkness.
Cells were then washed as before. After soaking in Hoechst's solvent for 15 minutes, the plate was sealed with 95% glycerol. Finally, cells
were observed under a fluorescence microscope for photographing, at randomly selected multiple fields of view (800) for the counting of foci. Each experiment was repeated three times.
| Western blot
RIPA lysis buffer was used to lyse cells and extract total protein.
The BCA method was adopted to measure the total protein concentration in each group. SDS-PAGE gels were prepared. Protein was electrophoretically transferred to a polyvinylidene difluoride (PVDF) membrane. Next, 5% BSA was applied to immersed PVDF membrane for 30 m at room temperature. Meanwhile, primary antibody (detail information provided in Table 3 ), diluted with TBST at 5% BSA, was added at 4°C overnight. After this, PVDF membrane was washed with TBST three times and incubated in horseradish enzyme-labeled secondary antibody (Abcam) with 5% BSA for approximately 1 hour at room temperature. Following this, it was washed by TBST three times once again. The PVDF membrane was then exposed, developed, cleaned and fixed. Image J was used to achieve semi-quantitative analysis of the cumulative optical density of the band and to calculate the relative expression of each protein of interest.
| Mouse allotransplantation assay
The 24 4-6-week-old Balb/c male mice used for this study were divided equally into four groups. All mice were purchased from the were injected into the peritumoral area every 5 days for mice in each group. Tumors were measured every week in three dimensions using vernier calipers. The tumor growth curve was calculated and plotted using the formula V = 1/2*length*width 2 . After day 30, mice were killed and tumor tissues were isolated. Samples were ground using liquid nitrogen and total RNA was extracted from tumors.
F I G U R E 1 Screening of Radiation-Related Gene IFITM1 in Head and Neck Tumor Cells. A, Twelve samples obtained from GSE9716 and were divided into two groups: radiosensitive-tumor, radioresistant-tumor, each group with six samples. The heat map showed the differential genes with screening conditions of P < 0.00001 and |log2 (Fold Change)| > 2. The red arrow indicates higher expressed genes IFITM1 and IFITM2 in radioresistant groups when compared with radiosensitive groups. B, 18 samples obtained from GSE9716 were divided into six groups: radioresistant-untreated, radioresistant-5 h-post-IR, radioresistant-24 h-post-IR, radiosensitive-untreated, radiosensitive-5 h-post-IR and radiosensitive-24 h-post-IR (each group had three samples). The heatmap shows the differential genes with screening conditions of P < 0.001 and |log2 (FoldChange)| > 1. The yellow box indicates that genes are highly expressed as the radiation time increases in radioresistant groups but expressed at low levels in radiosensitive groups, and the red arrow shows the most radioresistant-associated genes, IFITM1 and IFITM2. C, Venn diagram: The intersection of 119 highly expressed genes in radioresistant tumors and six radioresistant-associated differentially expressed genes was IFITM1/IFITM2. D, Prognosis KM curve: low IFITM1 expression contributes to the prognosis of patients with head and neck squamous cell carcinoma based on the TCGA database (P = 0.039). E-F, Analysis of differences in levels of IFITM1 and IFITM2 between normal tissue samples and tumor samples using the TCGA database. The expression of IFITM1 in tumors was 1.922 times than that in the adjacent tissues and *P < 0.05, which indicates that there were significant differences. However, the expression of IFITM2 in tumors was 0.824 times than that in the adjacent tissues and P > 0.05, which indicates no significant difference
Finally, the level of IFITM1 mRNA expression was evaluated using qRT-PCR for each group.
| Microarray
GSE9716 containing 38 samples (from GSM245389 to GSM245426) was used to detect differentially-expressed genes in radioresistant and radiosensitive human head and neck tumors before and after irradiation. In this study, the first 30 samples of GSM245389-GSM245418 were selected for analysis using GPL96 (Affymetrix Human Genome U133A Array). Among these, 12 samples of GSM245389-GSM245400 were divided into four groups: radioresis- 
| Statistical analysis
GraphPad Prism version 6.0 (GraphPad Software, La Jolla, CA, USA) was used to perform statistical analysis. An unpaired student's t test was used to examine differences between groups. Differences among the groups of samples were assessed by one-way ANOVA.
P < 0.05 was considered statistically significant. while the gene expression level was always weaker in radiosensitive cells, further lending weight to the conclusion that there exists a connection between the radiotherapy tolerance of head and neck tumor cells and IFITM1 and IFITM2. Moreover, patients were analyzed for prognosis using the TCGA database and the results showed that patients with higher IFITM1 expression saw a worse prognosis (P < 0.05) ( Figure 1D ), which further suggests that IFITM1 might be related to radiotherapy tolerance. Paired-differentiated analysis of cancer tissues and paracancerous tissues was applied to head and neck squamous cell carcinoma (HNSC) tumor samples using the TCGA database, which clarified that the fold change of IFITM1 was 1.922
( Figure 1E ) while that of IFITM2 was 0.824 ( Figure 1F ). Hence, IFITM1
was deemed to the closest irradiated gene in HNSC.
| IFITM1 overexpression in oral neoplasm cells and tissues
The expression of IFITM1 was analyzed in 19 cases of oral neoplasm and the corresponding paracancerous specimen before and after radiotherapy. IFITM1 expression level in cancer tissues was found to be higher than that in paracancerous tissues, and IFITM1 expression | 3121 in cancer tissues after radiotherapy was significantly higher than before radiotherapy (P < 0.05, Figure 2A) . H&E staining and immunohistochemistry showed that IFITM1 was mainly expressed in cytoplasm and membrane, while western blot of three 21-Gy patients' tissues showed higher expression of IFITM1 in post-irradiation groups when compared with pre-irradiation groups (P < 0.05, Figure 2B ). The scores of immunohistochemistry in different tissue samples before and after radiotherapy showed that the irradiation intensity of three samples was 15 Gy (one case increased), the irradiation intensity of eight samples was 18 Gy (five cases increased) and the irradiation intensity of eight samples was 21 Gy (five cases increased). Overall, the results illustrated that IFITM1 expression was significantly increased in 11 cases (P < 0.05, Figure 2C ). Figure 3E ,F). The straight-line graphs showed that IFITM1 expression peaked after radiation for 24-36 hours and the higher expression was sustained for 3 days until it sharply declined on the 4th day.
| IFITM1 expression inhibited decreased cell viability and promoted cell apoptosis
To further verify the relationship between IFITM1 and radiosensitivity of oral neoplasm, the expression of IFITM1 was disturbed with specific siRNA in CAL27 cells and TSCC1 cells. SiRNA of IFITM1 significantly reduced IFITM1 compared to the control group siNC before and after irradiation in two cell lines (P < 0.05, Figure 4A ,B). CCK8 assay was used to test cell viability after the radiotherapy dose was gradually increased, and the results showed that the cell survival rate gradually decreased after downregulating IFITM1 with significant statistical differences at doses of 6 and 8 Gy (P < 0.05, Figure 4C,D) . The colony formations of CAL27 and TSCC1 cell lines are shown in Figure 5A ,B at 8-Gy doses. The si-IFITM1 group was found to have the least number of colonies (P < 0.05). Similarly, cells were significantly apoptotic after inhibiting the expression of IFITM1 at 8-Gy doses (P < 0.05, Figure 5C ,D).
| IFITM1 expression inhibited upgraded caspase-3 vitality and expression, and resulted in DNA damage
Cell apoptosis and protein γ-H2AX expression were evaluated after F I G U R E 6 IFITM1 inhibition upgraded caspase-3 vitality and expression and DNA damage(A-B) The density ratios of the activation of procaspase-3 were first calculated in CAL27 and TSCC1 cells. The changes were expressed as the percentage of controls. Significant statistical difference occurred on the basis of **P < 0.01 compared to control group while ## P < 0.01 compared to siNC group. (C-D) Representative blots of caspase-3 protein in oral neoplasm cells compared to GADPH. **P < 0.01 compared to control group; ## P < 0.01 compared to siNC group. (E-F) γ-H2AX was stained with secondary antibody (red) and its nuclear counter stain was DAPI (blue). *P < 0.05 meant that there lay significant statistical difference compared to control group while # P < 0.05 compared to siNC group. Data were represented with mean and SD (n = 3). increased in CAL27 and TSCC1 cell lines (P < 0.05, Figure 6A-D) . The formation of γ-H2AX is related to DNA double-strand breaks (DSB).
There existed a linear positive correlation between the number of γ-H2AX foci and the number of DSB, and, hence, the formation of a focal spot of γ-H2AX molecules suggests DSB production. The outcomes showed that the γ-H2AX foci number in the si-IFITM1 group increased significantly (P < 0.05, Figure 6E ,F). The above results showed that, after inhibiting the expression of IFITM1, the apoptosis of oral neoplasm cells was significant. ship between IFITM1 and STAT1/2/3/p21 is demonstrated. [9] [10] [11] Changes in various proteins were measured using STAT1/2/3/p21 total protein antibody and its phosphorylation antibody, respectively, to observe the STAT1/2/3/p21 expression after inhibiting IFITM1 expression in drug-resistant oral neoplasm. This was intended to assess whether the signaling pathways in both oral neoplasm cells displayed a consistent trend while the STAT1/2/3 total protein showed little fluctuation, but the expression of p-STAT1/2/p21 was increased and the p-STAT3/p-p21 protein expression was reduced after IFITM1 knockdown (P < 0.05, Figure 7 ).
| IFITM1 in combination with radiation inhibited in vivo oral neoplasm tumorigenesis
We subcutaneously injected CAL27 cells transfected with siNC and si-IFITM1, respectively, which had been pre-treated with either 0 or 8 Gy radiation, to establish a mouse xenograft tumor model to investigate the effect of IFITM1 expression on the radioresistance of oral neoplasm in vivo at day 0. After day 5, the corresponding mice were treated with varying doses of radiation daily (0 or 8 Gy) and the growth of tumor volume was measured and recorded every 5 days. The entire F I G U R E 7 IFITM1 affects radiation tolerance of oral cancer cells by regulating STAT1/2/3/p21. The primary antibodies to IFITM1 and STAT1/2/3/p21 total protein were used to determine the amount of STAT1/2/3/p21 total protein. Phosphorylated protein was detected by phosphorylation of p-STAT1 (Ser727), p-STAT2 (Tyr690), p-STAT3 (Ser727) and pp21 (Thr145). The remainder of the test was converted to the relative value of the NC group. Each experiment was repeated 3 times and the results were shown by SD and mean. Significant statistical difference occurred on the basis of **P < 0.01 compared to control group while ## P < 0.01 compared to siNC group.
experimental design is simplified in Figure 8A . The IFITM1 expression in four groups of isolated tumor cells was tested using RT-PCR, which showed that si-IFITM1 successfully restrained IFITM1 expression in the implanted tumor cells while IFITM1 expression in the irradiated group was higher than in the non-irradiated group (P < 0.05, Figure 8B ). By comparing the tumor volume of four groups of mice, this research found that radiation significantly inhibited CAL27 cells in in vivo tumorigenesis, but radiation treatment combined with si-IFITM1 achieved better tumor suppression effects, and si-IFITM1 alone could lead to some inhibition of tumor formation (P < 0.05, Figure 8C ). In conclusion, this experiment illustrated that silencing IFITM1 combined with radiotherapy could help to enhance radiosensitivity and achieve the best anti-tumor effect of the treatments studied.
| DISCUSSION
In summary, the first step of this research was to assess the radioresistance effect of interferon-induced transmembrane protein 1 (IFITM1). IFITM1 has been reported to be a tumor promoter in many papers, for its role in cervical squamous cell carcinoma as one example. 12 Its suppression blocked the proliferation and invasion of breast cancer 9 and promoted the metastasis of human colorectal cancer. 13 In this research, the overexpression of IFITM1 was verified and the IFITM1 overexpression prognosis was, indeed, worse. Hence, we speculated that IFITM1 overexpression might be correlated with oral neoplasm.
The expression of IFITM1 has been found to be highly increased in cervical cancer, ovarian cancer and esophageal cancer. 12, 14, 15 Therefore, recent research posits that IFITM1 hastens the malignancy progression by increasing invasion and migration in gastric cancer, head and neck cancer, and glioma cells.
7 IFITM1 also appears to be a highly effective Cell survival assays, which are widely used in radiobiology research, have provided useful information regarding cells that do not die rapidly following radiation exposure. 3 For instance, we now know that the IFITM1 gene can be increased by radiation in a wide variety of tumor cell lines 3 and that it can regulate human cell proliferation after X-ray treatment. Although there are some valuable insights in this research, there is no doubt that problems remain. It is apparent that IFITM1 likely impacts not only oral neoplasm but also many other forms of cancer. It is also the case that radiotherapy has its own disadvantages, many of which are quite harmful. For oral neoplasm, there are still a large amount of issues to be addressed in future research. In this study as a whole, however, the overexpression of IFITM1 was seen to upgrade cell proliferation and cell apoptosis in CAL27, TSCC1 and KB cells. In contrast, cell proliferation and apoptosis can be inhibited by radiotherapy. As a result, the evidence points to strong support for the combination of radiotherapy with the inhibition of IFITM1. Therefore, this study may inform promising avenues for the treatment of oral neoplasm.
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